JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online June 13, 2008, 10.2967/jnumed.107.050138
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.050138v1
49/7/1090    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sotgia, B.
Right arrow Articles by Cecchi, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sotgia, B.
Right arrow Articles by Cecchi, F.
Journal of Nuclear Medicine Vol. 49 No. 7 1090-1096
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.050138

Clinical Investigation

Spatial Relationship Between Coronary Microvascular Dysfunction and Delayed Contrast Enhancement in Patients with Hypertrophic Cardiomyopathy

Barbara Sotgia1, Roberto Sciagrà1, Iacopo Olivotto2, Giancarlo Casolo3, Luigi Rega4, Irene Betti4, Alberto Pupi1, Paolo G. Camici5 and Franco Cecchi2

1 Department of Clinical Physiopathology—Nuclear Medicine Unit, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; 2 Regional Referral Center for Myocardial Diseases, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; 3 Division of Cardiology, Ospedale Versilia, Lido di Camaiore, Italy ; 4 Centre for Magnetic Resonance, Azienda Ospedaliera Universitaria Careggi, Florence, Italy; and 5 Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Imperial College, London, United Kingdom

Correspondence: For correspondence or reprints contact: Roberto Sciagrà, Nuclear Medicine, Department of Clinical Physiopathology, University of Florence; Viale Morgagni 85; 50134 Florence, Italy. E-mail: r.sciagra{at}dfc.unifi.it

To clarify the spatial relationship between coronary microvascular dysfunction and myocardial fibrosis in hypertrophic cardiomyopathy (HCM), we compared the measurement of hyperemic myocardial blood flow (hMBF) by PET with the extent of delayed contrast enhancement (DCE) detected by MRI. Methods: In 34 patients with HCM, PET was performed using 13N-labeled ammonia during hyperemia induced by intravenous dipyridamole. DCE and systolic thickening were assessed by MRI. Left ventricular myocardial segments were classified as with DCE, either transmural (DCE-T) or nontransmural (DCE-NT), and without DCE, either contiguous to DCE segments (NoDCE-C) or remote from them (NoDCE-R). Results: In the group with DCE, hMBF was significantly lower than in the group without DCE (1.81 ± 0.94 vs. 2.13 ± 1.11 mL/min/g; P < 0.001). DCE-T segments had lower hMBF than did DCE-NT segments (1.43 ± 0.52 vs. 1.91 ± 1 mL/min/g, P < 0.001). Similarly, NoDCE-C segments had lower hMBF than did NoDCE-R (1.98 ± 1.10 vs. 2.29 ± 1.10 mL/min/g, P < 0.01) and had no significant difference from DCE-NT segments. Severe coronary microvascular dysfunction (hMBF in the lowest tertile of all segments) was more prevalent among NoDCE-C than NoDCE-R segments (33% vs. 24%, P < 0.05). Systolic thickening was inversely correlated with percentage transmurality of DCE (Spearman {rho} = –0.37, P < 0.0001) and directly correlated with hMBF (Spearman {rho} = 0.20, P < 0.0001). Conclusion: In myocardial segments exhibiting DCE, hMBF is reduced. DCE extent is inversely correlated and hMBF directly correlated with systolic thickening. In segments without DCE but contiguous to DCE areas, hMBF is significantly lower than in those remote from DCE and is similar to the value obtained in nontransmural DCE segments. These results suggest that increasing degrees of coronary microvascular dysfunction might play a causative role for myocardial fibrosis in HCM.

Key Words: coronary microvascular dysfunction • fibrosis • hyperthrophic cardiomyopathy • myocardial blood flow • positron emission tomography

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 13A-14A. [Full Text]  






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.